nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Reviewers 2017
|
|
|
2018 |
62 |
C |
p. iii |
artikel |
2 |
Advances in sarcoma gene mutations and therapeutic targets
|
Gao, Peng |
|
2018 |
62 |
C |
p. 98-109 |
artikel |
3 |
Editorial Board
|
|
|
2018 |
62 |
C |
p. ii |
artikel |
4 |
Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
|
Røed Skårderud, Maria |
|
2018 |
62 |
C |
p. 61-73 |
artikel |
5 |
Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis
|
Gonzalez-Conchas, Galileo A. |
|
2018 |
62 |
C |
p. 1-8 |
artikel |
6 |
Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?
|
Picardi, Cristina |
|
2018 |
62 |
C |
p. 91-96 |
artikel |
7 |
PD-1 blockade in advanced NSCLC: A focus on pembrolizumab
|
Peters, Solange |
|
2018 |
62 |
C |
p. 39-49 |
artikel |
8 |
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis
|
Martel, Samuel |
|
2018 |
62 |
C |
p. 123-132 |
artikel |
9 |
Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe
|
Blok, E.J. |
|
2018 |
62 |
C |
p. 74-90 |
artikel |
10 |
Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
|
Krishnamurthy, Nithya |
|
2018 |
62 |
C |
p. 50-60 |
artikel |
11 |
The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review
|
de Groot, A.F. |
|
2018 |
62 |
C |
p. 18-28 |
artikel |
12 |
The lymphatics in infiltrating ductal carcinoma (IDC) of the breast
|
van Netten, Johannes P. |
|
2018 |
62 |
C |
p. 97 |
artikel |
13 |
The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer
|
Nakashoji, Ayako |
|
2018 |
62 |
C |
p. 9-17 |
artikel |
14 |
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
|
Lee, Alice |
|
2018 |
62 |
C |
p. 110-122 |
artikel |
15 |
Triple negative breast cancer in Asia: An insider’s view
|
Wang, Chao |
|
2018 |
62 |
C |
p. 29-38 |
artikel |